MassMutual Private Wealth & Trust’s MaxCyte MXCT Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-48	Closed	–	–	1774
2022 Q3	$0	Buy	+48	New	+$268	﹤0.01%	1745

Other funds holding MXCT

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

MassMutual Private Wealth & Trust's MXCT Position: Q4 2022 in Review

MassMutual Private Wealth & Trust sold out of MaxCyte (MXCT) in Q4 2022, closing a stake of 48 shares.

MassMutual Private Wealth & Trust first reported a position in MXCT in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 104 funds tracked by Wall St. Rank hold MXCT as of Q4 2022.

MassMutual Private Wealth & Trust reported no remaining MaxCyte position as of Q4 2022 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 48 MaxCyte shares in Q4 2022.
MassMutual Private Wealth & Trust first reported a position in MaxCyte in Q3 2022 and held it in 1 quarter.
MassMutual Private Wealth & Trust's MaxCyte position peaked at $0 in Q3 2022.
104 funds tracked by Wall St. Rank held MaxCyte as of Q4 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2022, filed 6 Jan 2023.